Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| SRC | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 345.0 | Evidence | |||||
| SRC | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
| SRC | CRKL | CRKL: Crk-like protein | 275.0 | Evidence | |||||
| SRC | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 275.0 | Evidence |
|
||||
| SRC | NCK2 | NCK2: Cytoplasmic protein NCK2 | 223.0 | Evidence | |||||
| SRC | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 221.0 | Evidence | |||||
| SRC | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 209.0 | Evidence | |||||
| SRC | EPHB4 | EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor | 206.0 | Evidence | |||||
| SRC | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 206.0 | Evidence | |||||
| SRC | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 206.0 | Evidence |
|
||||
| SRC | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 181.0 | Evidence |
|
||||
| SRC | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 181.0 | Evidence | |||||
| SRC | LYN | LYN: Tyrosine-protein kinase Lyn | 181.0 | Evidence | |||||
| SRC | CSK | CSK: Tyrosine-protein kinase CSK | 181.0 | Evidence |
|
||||
| SRC | SYK | SYK: Tyrosine-protein kinase SYK | 181.0 | Evidence |
|
||||
| SRC | HCK | N/A | 180.0 | Evidence | |||||
| SRC | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 180.0 | Evidence |
|
||||
| SRC | KIT | KIT: Mast/stem cell growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 167.0 | Evidence |
|
||||
| SRC | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 167.0 | Evidence | |||||
| SRC | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 156.0 | Evidence |
|
||||
| SRC | STAT3 | 156.0 | Evidence |
|
|||||
| SRC | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 147.0 | Evidence | |||||
| SRC | APS | SH2B2, APS: SH2B adapter protein 2 | 137.0 | Evidence | |||||
| SRC | VAV1 | VAV1, VAV: Proto-oncogene vav | 137.0 | Evidence | |||||
| SRC | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 137.0 | Evidence |
|
||||
| SRC | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 137.0 | Evidence | |||||
| SRC | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence |
|
||||
| SRC | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 135.0 | Evidence | |||||
| SRC | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 119.0 | Evidence | |||||
| SRC | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| SRC | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence |
|
||||
| SRC | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence |
|
||||
| SRC | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 117.0 | Evidence | |||||
| SRC | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 117.0 | Evidence |
|
||||
| SRC | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 109.0 | Evidence | |||||
| SRC | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 109.0 | Evidence | |||||
| SRC | INSR | INSR: Insulin receptor precursor | 101.0 | Evidence |
|
||||
| SRC | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 89.30 | Evidence |
|
||||
| SRC | JAK1 | 88.80 | Evidence | ||||||
| SRC | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 87.30 | Evidence | |||||
| SRC | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 82.10 | Evidence | |||||
| SRC | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 78.20 | Evidence | |||||
| SRC | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 76.90 | Evidence |
|
||||
| SRC | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 76.90 | Evidence | |||||
| SRC | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 66.50 | Evidence |
|
||||
| SRC | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 66.50 | Evidence | |||||
| SRC | GRB10 | N/A | 56.20 | Evidence |
|
||||
| SRC | GRAP | GRAP: GRB2-related adapter protein | 29.10 | Evidence | |||||
| SRC | DOK1 | DOK1: Docking protein 1 | 27.90 | Evidence |
|
||||
| SRC | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 26.40 | Evidence |
|
||||
| SRC | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 26.40 | Evidence | |||||
| SRC | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 23.50 | Evidence | |||||
| SRC | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 22.70 | Evidence | |||||
| SRC | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 22.70 | Evidence | |||||
| SRC | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 22.70 | Evidence |
|
||||
| SRC | WASPIP | N/A | 21.10 | Evidence | |||||
| SRC | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 19.70 | Evidence | |||||
| SRC | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 19.70 | Evidence |
|
||||
| SRC | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 17.30 | Evidence | |||||
| SRC | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 17.10 | Evidence | |||||
| SRC | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 15.10 | Evidence |
|
||||
| SRC | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 13.80 | Evidence | |||||
| SRC | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.80 | Evidence |
|
||||
| SRC | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 13.80 | Evidence | |||||
| SRC | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 11.20 | Evidence | |||||
| SRC | EFNB2 | EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor | 10.30 | Evidence |
|
||||
| SRC | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 9.89 | Evidence |
|
||||
| SRC | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 9.89 | Evidence | |||||
| SRC | CTTN | CTTN, EMS1: Src substrate cortactin | 9.89 | Evidence |
|
||||
| SRC | SOS1 | SOS1: Son of sevenless homolog 1 | 9.14 | Evidence | |||||
| SRC | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 7.59 | Evidence | |||||
| SRC | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 7.40 | Evidence | |||||
| SRC | EPOR | EPOR: Erythropoietin receptor precursor | 6.52 | Evidence | |||||
| SRC | EFNB1 | EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor | 6.13 | Evidence |
|
||||
| SRC | NRAS | NRAS, HRAS1: GTPase NRas precursor | 5.08 | Evidence | |||||
| SRC | IKBKE | IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit | 4.68 | Evidence | |||||
| SRC | SLC9A3 | SLC9A3, NHE3: Sodium/hydrogen exchanger 3 | 4.12 | Evidence | |||||
| SRC | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 3.57 | Evidence |
|
||||
| SRC | CAV1 | CAV1, CAV: Caveolin-1 | 3.49 | Evidence |
|
||||
| SRC | GIT2 | N/A | 3.34 | Evidence | |||||
| SRC | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 2.94 | Evidence | |||||
| SRC | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 2.65 | Evidence | |||||
-